4/A//SEC Filing
GLENN JOHN 4/A
Accession 0001415889-25-010289
CIK 0001325618other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:10 PM ET
Size
6.2 KB
Accession
0001415889-25-010289
Insider Transaction Report
Form 4/AAmended
IRADIMED CORPIRMD
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-20−5,796→ 11,592 totalFrom: 2024-06-20→ Common Stock (5,796 underlying)
Footnotes (3)
- [F1]When vested, restricted stock units ("RSUs") are convertible into common stock on a one-for-one basis.
- [F2]On April 4, 2025, the Reporting Person filed a Form 4, which inadvertently stated in Column 5 of Table II that 5,796 RSUs were acquired instead of disposed. This inadvertent misstatement has been corrected in this amended filing to note that 5,796 RSUs were disposed.
- [F3]On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001253497
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:10 PM ET
- Size
- 6.2 KB